Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Detection of p53 mutations using nonradioactive SSCP analysis: p53 is not frequently mutated in myelodysplastic syndromes (MDS).

Annals of hematology - 1 Nov 1993

Neubauer A, Brendel C, Vogel D, Schmidt C A, Heide I, Huhn D

Abstract excerpt

p53 is one of the most frequently mutated genes in human cancers. Since p53 has been implicated in lymphatic and some myeloid leukemias, such as the blastic phase of chronic myelogenous leukemia, we sought to address the role of p53 gene mutations within exons 4-9 in myelodysplastic syndromes (MDS), a myeloid preleukemic condition. In order to avoid the potential hazard of using radioactive single-strand...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alleles
Share to DNA, Single-Stranded
Share to Genes, p53

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Mutation

Share to Nucleic Acid Conformation

Share to Point Mutation

Share to Polymorphism, Genetic

Share to Tumor Cells, Cultured

Source

Identifiers

PMID: 8241345
DOI: 10.1007/BF01715051

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Detection of p53 mutations using nonradioactive SSCP analysis: p53 is not frequently mutated in myelodysplastic syndromes (MDS).PMID 8241345Read ↗

Mutations of the p53 gene in myelodysplastic syndrome (MDS) and MDS-derived leukemia.Semantic proximity Read ↗

Mutations in the p53 gene in myelodysplastic syndromes.Semantic proximity Read ↗

P53 mutation in advanced stage of primary myelodysplastic syndrome.Semantic proximity Read ↗

Detection of serum anti p53 antibodies and their correlation with p53 mutations in myelodysplastic syndromes and acute myeloid leukemia.Semantic proximity Read ↗

TP53 mutations emerge at early phase of myelodysplastic syndrome and are associated with complex chromosomal abnormalities.Semantic proximity Read ↗

Mutations of the p53 tumour suppressor gene in haematologic neoplasms.Semantic proximity Read ↗

Mutations of the p53 gene in myelodysplastic syndrome and overt leukemia.Semantic proximity Read ↗

Frequent mutations in the p53 gene in human myeloid leukemia cell lines.Semantic proximity Read ↗

Mutations With Loss of Heterozygosity of p53 Are Common in Therapy-Related Myelodysplasia and Acute Myeloid Leukemia After Exposure to Alkylating Agents and Significantly Associated With Deletion or Loss of 5q, a Complex Karyotype, and a Poor PrognosisSemantic proximity Read ↗

Frequent mutations in the p53 gene in human myeloid leukemia cell linesSemantic proximity Read ↗

Detection of p53 mutations in hematological malignancies: comparison between immunocytochemistry and DNA analysis.Semantic proximity Read ↗

Relationship between p53 gene mutations and multidrug resistance (mdr1) gene expression in myelodysplastic syndromes.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.